10x Genomics (TXG) Interest & Investment Income (2018 - 2026)

10x Genomics has reported Interest & Investment Income for 9 years, with the latest figure at $5.0 million in Q1 2026.

• Quarterly Interest & Investment Income rose 36.03% year-over-year to $5.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.4 million (up 19.55% YoY) and the FY2025 annual result came in at $20.0 million, up 5.91% from the prior year.
• Interest & Investment Income declined to $5.0 million in Q1 2026 per TXG's latest filing, from $6.9 million in the prior quarter.
• Over five years, Interest & Investment Income peaked at $6.9 million in Q4 2025 and troughed at $569000.0 in Q1 2022.
• A 5-year average of $4.0 million and a median of $4.3 million in 2023 frame the typical range for Interest & Investment Income.
• The sharpest annual moves came in 2022 and 2025: Interest & Investment Income soared 5644.9% in 2022, then retreated 22.17% in 2025.
• Over 5 years, Interest & Investment Income stood at $2.8 million in 2022, then surged by 63.98% to $4.6 million in 2023, then decreased by 2.34% to $4.5 million in 2024, then soared by 52.88% to $6.9 million in 2025, then decreased by 27.25% to $5.0 million in 2026.
• According to Business Quant data, Interest & Investment Income over the past three periods registered $5.0 million, $6.9 million, and $5.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.